On sale!

Pen Semaglutide 4 mg – Ozempic pen

The original price was: €132.The current price is: €127.

Pen Semaglutide 4 mg – Ozempic pen

Active ingredient: Semaglutide
Category: GLP-1 (glucagon-like peptide-1) receptor agonist
Pharmaceutical form: Solution for injection in pen

  • Check Mark Shipping (if the product is in stock): 3 business days for processing and 5 to 20 business days for shipping
  • Check Mark Processing and shipping costs: €27 throughout Italy
  • Stripe
  • Visa Card
  • MasterCard
  • American Express
  • Discover Card
  • PayPal
  • Apple Pay
Available payment methods: Bitcoin - Bank transfer - Credit card - Neteller

Understanding Ozempic Pen (Semaglutide)

Ozempic Pen contains semaglutide, an active ingredient widely used in the treatment of type 2 diabetes. Semaglutide belongs to the class of GLP-1 receptor agonists, drugs that act on both blood sugar control and appetite regulation.

In addition to its use in diabetes, Ozempic Pen with Semaglutide is also used in weight management in individuals with specific metabolic conditions, thanks to its ability to reduce hunger, increase satiety, and facilitate a decrease in calorie intake.


Advantages of Ozempic Pen

The Ozempic Pen formulation is designed to ensure convenience, precision, and comfort during treatment:

  • Ease of use: the pen allows self-administration of the injection without the need for medical assistance. Its ergonomic design makes it easy to use, even for those with no experience.

  • Precise dosing: allows you to accurately select the dose of Semaglutide, reducing the risk of errors.

  • Practicality and discretion: pre-filled, compact, and easy to carry, ideal for everyday use.

  • Less anxiety about injections: the needle is generally hidden, helping to reduce psychological discomfort.

  • Greater adherence to therapy: ease of use promotes continuity of treatment.


How Semaglutide works

Semaglutide mimics the action of the natural hormone GLP-1, acting on several mechanisms:

  • stimulates the release of insulin when blood sugar levels are high;

  • reduces glucose production by the liver;

  • slows gastric emptying, increasing the feeling of fullness;

  • helps reduce overall calorie intake.


Benefits of Ozempic Pen with Semaglutide

The use of Ozempic in Pen offers numerous clinical and metabolic benefits:

  • Better blood sugar control, thanks to targeted insulin stimulation;

  • Supports weight loss by reducing appetite;

  • Cardiovascular benefits, with a reduction in the risk of major cardiac events;

  • Weekly administration, more convenient than daily medications;

  • Low risk of hypoglycemia when used alone.


Role of Semaglutide in treatment

Semaglutide is the active ingredient responsible for the therapeutic effect of Ozempic in Pen. It can be used:

  • as monotherapy, when diet and exercise are not sufficient;

  • in combination with other antidiabetic drugs, if more effective blood glucose control is required.


Possible side effects

The most common side effects of Semaglutide include:

  • nausea and gastrointestinal disorders;

  • diarrhea or constipation;

  • abdominal pain;

  • headache and fatigue;

  • reduced appetite.

More rarely, pancreatitis, kidney problems, or thyroid disorders may occur. It is always advisable to consult a doctor.


Guidelines for the use of Ozempic in Pen

  • Initial dose: 0.25 mg once a week for 4 weeks (adjustment phase).

  • Maintenance dose: 0.5 mg per week.

  • Increase: if necessary, the dose may be increased to 1 mg or 2 mg weekly, depending on tolerance.

The injection is subcutaneous and can be administered in the thigh, abdomen, or arm.


Proper storage

  • Before use: store in the refrigerator at 2–8 °C, without freezing.

  • During use: store in a refrigerator or at a temperature below 30°C.

  • Protect from light and keep out of reach of children.


In summary

Ozempic Pen with Semaglutide is a modern and effective solution for type 2 diabetes control and weight management, combining clinical efficacy, ease of use, and a well-studied safety profile.